Market

The BIRAC AcE Fund aims to accelerate growth of biotech startups

Faced with the under-performance of the Jan Aushadhi scheme, the government has decided to revamp the scheme

22 corporates have crossed the growth of IPM for the month of February 2015 amongst top 50

Will help patients suffering from Critical Limb Ischemia (CLI)

Acquires certain oncology products and pipeline compounds from GSK

To buy GSK’s opiates business in Australia

Advocate key intervention strategies to address growing burden

To help India’s pharmaceutical excipient manufacturers demonstrate regulatory compliance, safety and quality

Dr. Reddy’s Laboratories’ (DRL) Custom Pharmaceutical Services (CPS) division has expanded its existing custom service facilities…

Discussions will be held on opportunities for growth, challenges and way forward

‘Partnering for Purpose’ was the theme for this year's conference

FDA inspected the plant in January this year and listed six observations on the manufacturing processes at the plant

Lupin and Celon Pharma have entered into a definitive agreement under which the companies will jointly develop fluticasone/…

The multiple dosing studies are expected to be completed by Q2 2015

The product has recently been introduced under the brand Accofil

Forays into the Rs 800-crore nasal inhaler segment

The company plans to commence shipping of Ashlyna immediately

Cipla has been awarded US $188.95 million of Global Fund ARV tender

Under the agreement Mylan will distribute Sovaldi and Harvoni in India

31 corporates have shown growth more than 10 per cent amongst the top 50